Page last updated: 2024-08-17

methylene blue and Diabetic Neuropathies

methylene blue has been researched along with Diabetic Neuropathies in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kulkarni, SK; Patil, CS; Singh, S; Singh, VP1
Byers, PD; Page, KM1

Other Studies

2 other study(ies) available for methylene blue and Diabetic Neuropathies

ArticleYear
Modulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy.
    Pharmacology, 2004, Volume: 72, Issue:3

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Dose-Response Relationship, Drug; Female; Hyperalgesia; Male; Methylene Blue; Mice; NG-Nitroarginine Methyl Ester; Pain Threshold; Phosphodiesterase Inhibitors; Piperazines; Purines; Rats; Rats, Wistar; Sildenafil Citrate; Sulfones

2004
Axonic swellings demonstrated by a supravital methylene blue technique.
    Acta neurologica Scandinavica, 1969, Volume: 45, Issue:3

    Topics: Aged; Amputation, Surgical; Amyotrophic Lateral Sclerosis; Anemia, Hypochromic; Axons; Bone Neoplasms; Chondrosarcoma; Diabetic Neuropathies; Edema; Glycosuria; Humans; Hyperglycemia; Injections, Intramuscular; Leg; Male; Methods; Methylene Blue; Motor Neurons; Muscles; Muscular Diseases; Neuritis; Neuromuscular Junction; Porphyrias; Staining and Labeling; Vitamin B Deficiency

1969